Command Palette

Search for a command to run...

Clinical Trials · NCT04532801

Evaluation of Kisspeptin Glucose-Stimulated Insulin Secretion With Physiologic Mixed Meal Tolerance

WithdrawnPhase 1Kisspeptin (Prohibited)
Phase
Phase 1
Recruitment status
Withdrawn
Sponsor
Stephanie B. Seminara, MD
Enrollment
0
Start date
Sep 2019
Locations
1 site, United States
Primary endpoint
Beta-cell responsivity index
View Kisspeptin compound reference